Navigation Links
Waters Corporation Announces U.S. Drug Enforcement Administration Acquires Waters ACQUITY UPLC System to Train Forensic Chemists in Drug Screening and Profiling
Date:4/29/2009

MILFORD, Mass., April 29 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT) announced today that the United States Drug Enforcement Administration (U.S. DEA) purchased a Waters(R) ACQUITY(R) UltraPerformance Liquid Chromatograph for the purpose of training new forensic chemists at the Special Testing and Research Laboratory in Dulles, Va.

Forensic laboratories are an important resource in assisting local, state and federal law enforcement agencies in monitoring and combating illicit drug abuse and trafficking, including the diversion of legally-manufactured pharmaceuticals into illegal markets. For example, data collected by the DEA from forensic laboratories about the regional use of prescription pain medicines like oxycodone and hydrocodone for non-medical purposes informs drug policy and drug enforcement initiatives and helps solve crimes. Each year, several million seized drug items are analyzed by the nation's network of government and private forensic laboratories.

Since 2004, the DEA has applied Waters ACQUITY UltraPerformance LC(R) (UPLC(R)) technology for drug profiling and has investigated this technology for drug screening analyses.

For drug profiling applications, where experts analyze trace impurities such as precursor chemicals in synthetic drugs or the constituents of natural products such as those derived from opium, a combination of UPLC and mass spectrometry (UPLC/MS/MS) has been shown to offer 2X better resolving power than HPLC and greater specificity and sensitivity than HPLC paired with photodiode array detection. These trace impurities can be important in matching a seized drug to a particular individual and potentially linking it to other cases where a similar impurity profile has been generated.

The DEA's most recent acquisition of an ACQUITY UPLC System complements its growing number of Waters ACQUITY UPLC and UPLC/MS/MS analytical systems deployed at DEA laboratories around the country.

For more information on Waters products for UPLC, visit www.waters.com/uplc.

About Waters Corporation (www.waters.com)

For 50 years, Waters Corporation (NYSE: WAT) creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.58 billion in 2008 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, ACQUITY, UPLC, UltraPerformance LC, and ACQUITY UPLC are trademarks of Waters Corporation.


'/>"/>
SOURCE Waters Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. elephantjournal.com: Is Fluoridating Waters Giving Kids Cavities?
2. Video: Waters Highlights Impact of ACQUITY UPLC with Peer-to-Peer Scientist Testimonials
3. InVitria Headlines Sponsorship of WilBio's Waterside Conference
4. Waters Corporation Announces the Purchase of UPLC/MS Systems by the National Cancer Institute for Advanced Metabolomics Research
5. Red Cross Readies Shelters As Flood Waters Threaten to Top Levees
6. American Lung Association of Upper Midwest Offers Tips on Dealing With Floodwaters
7. AWWA partners with WaterSmart Innovations conference
8. Waters and LabVantage Partnership Targets Laboratory Informatics Integration to Maximize Data Management and Quality of Work
9. Next Generation Waters Successfully Reaches Over 300 Stores!
10. Leading Spring Water Brands From Nestle Waters Team Up With the American Heart Association START! Initiative
11. Waters To Unveil Xevo TQ MS Applications for Improved Drug Discovery at AAPS 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2016)... ... May 30, 2016 , ... ... Shaolin warrior 8-day-8 and 8-night special intensive summer training camp starts on June ... summer camp offers families and children a fun and unique experience with an ...
(Date:5/29/2016)... ... May 29, 2016 , ... Whole Health Supply is ... new KlipPro KP-240L clipper is available to the public. This is an unusual clipper ... wider than the average clipper. , Everything about this product is concentrated on ease ...
(Date:5/28/2016)... ... May 28, 2016 , ... "Color Grading media can ... drop a preset onto their media," said Christina Austin - CEO of Pixel Film ... can quickly and easily add stylish color grades to their footage. A LUT is ...
(Date:5/28/2016)... ... ... of the city where’s it’s easy to spot the neon lights of chains serving fast ... diners with a taste for real food. , On May 13, the Best ... urban casual restaurant focusing on dishes made by hand with wholesome, organic ingredients that are ...
(Date:5/27/2016)... ... 2016 , ... Two director-level employees of Horizon Blue Cross Blue Shield of ... 2016 honorees. The award recognizes businesswomen who excel in their fields and who ... the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and Theresa ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... May 26, 2016 Since its ... into an essential life science tool for conducting genetic ... BCC Research reveals in its new report that the ... phase, one powered by a range of new applications ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 /PRNewswire/ ... dringenden Bedarf zur Steuerung ... N.V. (NASDAQ: QGEN ; Frankfurt Prime ... Entwicklungsvereinbarung mit Therawis Diagnostics GmbH zur Entwicklung und ... sein. Ein erstes Projekt wird die Entwicklung und ...
(Date:5/25/2016)... , May 25, 2016  According to Kalorama Information, ... billion in 2015.  Though these are challenging times ... opportunity for success for companies that remain optimistic ... of new growth prospects medical device companies spend ... and development (R&D) than do companies in other ...
Breaking Medicine Technology: